Article Details

Surface Oncology (NASDAQ:SURF) Receives “Buy” Rating from Jonestrading

Retrieved on: 2022-06-05 22:11:18

Tags for this article:

Click the tags to see associated articles and topics

Surface Oncology (NASDAQ:SURF) Receives “Buy” Rating from Jonestrading. View article details on hiswai:

Excerpt

Read Surface Oncology (NASDAQ:SURF) Receives “Buy” Rating from Jonestrading at Defense World.

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up